Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 4/5/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Mitchell Gold?

Mitchell H. Gold

Chief Executive Officer

Dendreon Corporation

HQ Phone:  (206) 256-4545

Direct Phone: (206) ***-****direct phone

Email: m***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Dendreon Corporation

1301 2Nd Ave. Suite 3200

Seattle, Washington,98101

United States

Company Description

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, en...more

Background Information

Employment History

President and Chief Executive Officer

Shareholder.com incorporated


Affiliations

University of Washington/Fred Hutchinson Cancer Research Center Prostate Cancer Institute

Board Member


Affiniscape Inc

Board Member


Phacilitate Limited

Advisory Board Member


Washington Biotechnology & Biomedical Association

Board Member


InvestorVillage

Board Member


Info.Resource , Inc.

Board Member


Xenotope Diagnostics Inc.

Board Member


Catalyst Medical Solutions

Board Member


Immunex Corporation

Co-Founder


PE Hub

Board Member


Jennerex , Inc.

Board Member


ICOS Corporation

Co-Founder


Education

B.S.

University of Wisconsin-Madison


M.D.

Cancer Research Institute


M.D.

Rush Medical College


MD/PhD/CEO of Dendreon


Web References(182 Total References)


Team | Alpine Bioventures

www.alpinebioventures.com [cached]

Mitchell H. Gold, MD
Founder & Managing Partner Dr. Mitchell H. Gold has a lifelong commitment to helping patients with cancer, stemming from the loss of his 26-year old mother to metastatic breast cancer when he was four years old. This loss served as the catalyst for Dr. Gold's career in medicine and desire to transform scientific breakthroughs into a reality for patients. As CEO of Dendreon Corporation, Dr. Gold and his team developed a new class of therapies called active cellular immunotherapy (ACI), designed to engage a patient's own immune system against cancer. Dendreon ushered in an entirely new era in cancer treatment with the FDA approval of PROVENGE® (sipuleucel-T), in April 2010. Provenge is now marketed worldwide by Valeant Pharmaceuticals (NYSE:VRX). Read more Dr. Gold was chairman and founder of Alpine Biosciences, a privately-held biotech company dedicated to developing the next generation of cancer and orphan disease treatments via a best-in-class nano-particle delivery system. Alpine Biosciences was sold to Oncothyreon (NASDAQ: ONTY) in August 2014. For his contributions to science and the treatment of cancer, Dr. Gold was named a runner up to Steve Jobs and Jeff Bezos for "Smartest CEO" by Fortune Magazine and was honored with the 2011 Oliver R. Grace Award by the Cancer Research Institute. A Chicago native, Dr. Gold graduated from the University of Wisconsin and Rush University Medical School in Chicago and was a urology resident at the University of Washington. Dr. Gold is on Twitter @Alpine_Mitch Mitchell Gold speaks at Madison, WI Bioscience Vision Summit


Bio Roundup: Spinraza Woes, Science March, Baseline Launch & More | Xconomy

www.xconomy.com [cached]

-Controversial former Dendreon CEO Mitch Gold is back on Wall Street, now that his latest startup, Seattle-based Alpine Immune Sciences, has cut a deal to merge with struggling Nivalis Therapeutics (NASDAQ: NVLS) in a bid to go public.
The combined company will be run by Gold and take on the Alpine name.


Dendreon Restructuring Call

openicon.com [cached]

Mitchell H. Gold, MD, Dendreon's CEO, led a analyst conference call to discuss restructuring plans.


Lyman BioPharma Consulting LLC

lymanbiopharma.com [cached]

Alpine Immune Sciences - Immunotherapy company headed by former Dendreon CEO Mitch Gold


Prostate Cancer Survivors Celebration Breakfast | Cathi Hatch

www.cathihatch.com [cached]

The keynote address was fascinating by Dr. Mitchell Gold, CEO and President of Dendreon Corporation.
He has overseen the growth of Dendreon from a $40 million dollar market cap to over $6 billion dollars today. He talked about how the loss of his mother to breast cancer when she was only 26 years old and when he was five years old has driven his focus toward his life's work of finding a cure for cancer.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory